Top CROs can look forward to ‘five years of growth’
April 8, 2009Research and Development CRO
The current economic downturn is having a braking effect on the top 10 contract research organisations, but a new report …
Quintiles completes 400th trial using electronic data capture
April 7, 2009Research and Development CRO, Quintiles
Quintiles has completed its 400th clinical trial using Electronic Data Capture (EDC). In addition to starting its 400th EDC trial, …
MEP animal testing vote angers welfare groups
April 7, 2009Research and Development, Sales and Marketing Animal testing, Europe, preclinical
The European Parliament's Agriculture and Rural Development Committee has been accused of watering down proposals drawn up by the European …
A new approach to CRO partnerships
April 6, 2009Research and Development Pfizer, UK, clincal, partnerships
Contract research organisations now play an indispensable role in helping pharmaceutical companies develop their drugs. But as the number and …
Lilly forges risk-sharing R&D alliance with India’s Zydus
April 6, 2009Research and Development Asia, India, lilly
Eli Lilly has forged a research collaboration with India's Zydus Cadila that sees the two companies combine their efforts in …
Med comms ‘needs to be more transparent’
April 6, 2009Medical Communications Liberation
There needs to be greater transparency in medical communications if negative views of the pharma sector are to be countered, …
Consolidation wave expected in contract manufacturing
April 6, 2009Research and Development CRO
The mergers and acquisitions that have become a feature of the contract research organisation (CRO) sector in recent years look …
Pfizer halts Sutent head-to-head trial
April 6, 2009Research and Development, Sales and Marketing Cancer, Pfizer, Sutent
Pfizer has halted a late-stage breast cancer trial between Sutent and Roche's Xeloda, after the study failed to show significant …
Working Life: Maneesh Juneja
April 3, 2009Research and Development GSK, productivity
How did you find your way into your current role? After graduating with a degree in business & computing, I …
Consortium wins US biodefence contract
April 3, 2009Manufacturing and Production biologics, vaccines
A consortium of US and UK companies has been awarded an $11 million grant from the US Government to speed …
iX Group buys manufacturing audit company
April 3, 2009Business Services Rephine
iXGroup, owners of Medix UK, has acquired Rephine, the pharmaceutical audit and consultancy specialists. Rephine was founded in 1998 and …
NHS health and social care pilots begin
April 3, 2009NHS
A raft of pilot schemes designed to bridge gaps between health and social care services started this week. The nationwide …
US prescription growth stalls in 2008
April 3, 2009Sales and Marketing US
US prescription sales growth was just 1.3% in 2008, well down on the typical 5%-plus in recent years, according to …
Inflammatory bowel disease care ‘unacceptably’ variable
April 2, 2009GI, NHS
The standard of care for patients with inflammatory bowel disease in the UK remains "unacceptably" variable. The second national audit …
Telehealth awareness reaches tipping point
April 2, 2009Research and Development, Sales and Marketing digi, healthcare
Analysts Datamonitor believe that telehealth has reached the tipping point in terms of awareness, with IBM following Intel's entrance into …
Takeda chooses US base for its global development headquarters
April 2, 2009Research and Development Takeda
Takeda Pharmaceutical Company is shifting its global development HQ from Japan to the US. The move will see that function …
Bayer Schering Pharma restricts UK distribution
April 2, 2009Manufacturing and Production Bayer
Bayer Schering Pharma has joined the ranks of firms switching to restrictive distribution arrangements in the UK. The pharma company, …
Over 40s to have health checks on NHS
April 1, 2009NHS
Everyone in England aged 40-74 is to get a health check on the NHS in an attempt to identify major …
Roche lines up manufacturing and R&D reshuffle
April 1, 2009Sales and Marketing Genentech, Roche
Genentech's decision to succumb to Roche's $48.8 billion merger bid has signalled a revamp of manufacturing, R&D and other divisions …
Latest content
